Tonight, SpaceX prices. Tomorrow morning, everything shifts.

The offer is $135 per share. The implied valuation is $1.75 trillion. Ticker SPCX hits Nasdaq at the open June 12, and for the first time ever, institutional capital will have direct access to the category leader in orbital infrastructure. That is not a small thing. That is a structural change in how money flows through this entire sector.

Rocket Lab USA ($RKLB) has been the proxy trade for that moment. Whether it stays that way after SPCX opens is the only question that actually matters right now.

Here’s where analyst targets sit heading into tonight:

• Citizens JMP – Buy | $95 (raised from $85)
• Cantor Fitzgerald – Overweight | $96 (raised from $85)
• Goldman Sachs – Neutral | $76 (raised from $73)
• Clear Street – Buy | $129 (raised from $98)
• Wells Fargo – Hold | target undisclosed
• Consensus (15 analysts) – Buy | Avg ~$105 | Range: $60 – $150

That $90 spread between the low and high target is worth sitting with for a moment. It’s not noise. It reflects a genuine disagreement about whether RKLB is a business being valued on execution or a sentiment vehicle being valued on proximity to SpaceX. Probably both. The ratio of which is what’s being debated.

Let’s talk about the actual business, because it’s easy to lose that in the IPO noise.

Rocket Lab is a vertically integrated space company operating out of Long Beach, California. Founded by Sir Peter Beck in 2006. Two segments: Launch Services, built around the Electron small-lift rocket and the hypersonic HASTE vehicle, and Space Systems, which covers spacecraft design, satellite components, manufacturing, and on-orbit management. The company is not a pure launch play anymore. It hasn’t been for a while. Space Systems is now the larger revenue contributor and growing faster than the launch side.

Two recent acquisitions matter here. Mynaric AG closed in April 2026 for roughly $160 million, adding laser communications hardware to the stack. Motiv Space Systems closed in May 2026, now operating as Rocket Lab Robotics. Both moves point toward the same thing: Beck is building something with more surface area than a launch company. Whether the market is paying for that vision or just for the SpaceX correlation is a separate conversation.

Neutron is still on track for a late 2026 first launch. Medium-lift, targeting commercial and national security payloads. Pre-revenue. Carries meaningful execution risk. That’s the asset that either expands the addressable market significantly or becomes a multi-quarter overhang if it slips.

The Q1 Numbers

• Revenue: $200.3M vs. ~$189.4M est. (+63.5% YoY) – first quarter above $200M
• Space Systems: $136.7M vs. $132.1M est. (+57.2% YoY)
• Launch Services: $63.7M vs. $59.0M est. (+78.9% YoY)
• GAAP Gross Margin: 38.2% | Non-GAAP: 43%
• GAAP Net Loss: $45.0M (vs. $60.6M loss a year ago)
• Adj. EBITDA Loss: $11.8M vs. $25.1M expected
• Backlog: $2.2B (+20.2% sequentially, +108% YoY)
• New Contracts: 31 Electron/HASTE contracts in Q1 alone – more than all of 2025
• Neutron Manifest: 5 new dedicated launch agreements; 70+ total missions
• Q2 Guidance: $225M – $240M (vs. $207.5M LSEG estimate)

That EBITDA line is the one that got people’s attention. Coming in at $11.8M versus a $25.1M expected loss is not a rounding error. The stock jumped 34% in a single session after that report – its best day in history. The backlog doubling year-over-year is real signal. So is the fact that Q1 contract volume outpaced all of 2025 in a single quarter.

The fundamentals are good. That part is clear.

What’s interesting is how much of the current price is actually about SpaceX and not about those numbers. The stock is up more than 400% over the past year. Roughly 85% year-to-date. RKLB closed at $105.05 on June 9. That move started well before Q1 earnings. It accelerated as the SpaceX IPO timeline became real. Institutional investors mapping peer valuations ahead of a $1.75 trillion comp had exactly one liquid benchmark available in public markets. RKLB was it.

Slight tangent, but it matters: SpaceX’s own financials are messier than the IPO coverage suggests. The company posted a GAAP net loss of $4.94 billion in 2025. Q1 2026 added another $4.28 billion in losses, driven largely by xAI integration costs. Starlink is doing the heavy lifting on revenue at an estimated $11.3 billion in 2025. The $135 IPO price implies roughly 94x revenue. SPCX is not being valued on earnings. It’s being valued on the belief that orbital infrastructure becomes the backbone of the global economy over the next decade. That may be correct. But it means the valuation on RKLB – currently trading near 96x EV/Sales – is being pulled upward by the same gravitational field, not just by operational performance.

On the macro side, the demand picture is genuinely accelerating. The Golden Dome missile defense initiative is expanding the defense contract pool across the sector. NASA’s Artemis program continues to build out a commercial supply chain. The Pentagon’s Space Development Agency Tranche II and III satellite programs – Rocket Lab is already contracted on both – provide multi-year government revenue floors that most competitors can’t claim. These are not speculative tailwinds. They’re contracts already in the $2.2 billion backlog.

The SpaceX IPO was 3.5x oversubscribed as of this week, drawing more than $250 billion in investor demand against a $75 billion raise. Thirty percent of the float is earmarked for retail. That level of capital attention does not stay contained. It moves through adjacent names. RKLB has been the primary beneficiary of that spillover.

Three things to watch over the next 72 hours, in order of importance.

First, how SPCX opens tomorrow and what the capital flows look like immediately after. If institutions rotate out of RKLB to fund SPCX positions, you’ll see it in the order flow. If SPCX opens strong and the sector lifts broadly, RKLB has more room. The direction of that trade in the first hour tells you a lot about which scenario is playing out.

Second, the technical picture. RKLB held above $100 after the Q1 earnings move and that level has become psychological support. The stock pulled back 4.85% on June 9, suggesting some options positioning ahead of tonight. A hold above $100 on SPCX’s debut is a constructive signal. A break below $95 reopens the multiple compression conversation in a real way. Clear Street’s $129 target is the upside reference point if momentum continues.

Third – and this one gets less attention – CFO Adam Spice has filed intent to sell 63,000 shares. That’s not a red flag on its own. Executives sell for all kinds of reasons. But it’s worth tracking alongside the broader insider activity picture, particularly as the stock approaches all-time high territory.

After that: Q2 earnings. The $225M – $240M guidance range is already well above the $207.5M LSEG consensus that existed before the print. Execution on that guide is what justifies the current multiple in the absence of the SpaceX IPO effect as a driver. Goldman Sachs and Wells Fargo are still the skeptics on the street. Any upgrade from either of those firms would carry meaningful weight.

Here’s where I’m at on this. The Rocket Lab business is not the problem. Revenue is accelerating. Margins are improving. The backlog doubled. New contract volume in Q1 exceeded all of 2025. Neutron is on schedule. The acquisition strategy is coherent. If you’re evaluating the company, the operational story holds up.

The question is simpler and harder than that. RKLB at $105 is pricing in a version of the future where Rocket Lab becomes critical infrastructure for the orbital economy. That version may be correct. But the path to getting there runs directly through Neutron’s first launch, Q2 execution, and whether the SpaceX listing creates a rotation out of the proxy or a broader sector re-rating that carries RKLB higher alongside it.

Tomorrow morning’s open is not the end of the story. It might just be the beginning of a very different one.

For informational purposes only.